Strict Standards: DateTime::createFromFormat(): We selected 'Europe/Berlin' for 'CEST/2.0/DST' instead in /homepages/10/d139440268/htdocs/oncodev/vendor/symfony/http-foundation/Response.php on line 231

Strict Standards: DateTime::createFromFormat(): We selected 'Europe/Berlin' for 'CEST/2.0/DST' instead in /homepages/10/d139440268/htdocs/oncodev/vendor/symfony/http-foundation/Response.php on line 231
Clinical http://oncotherm.com/en/taxonomy/term/39 en New Installation of EHY-2000 Device - BioMed Clinic, Bad Bergzabern http://oncotherm.com/en/news-events/new-installation-ehy-2000-device-biomed-clinic-bad-bergzabern <span>New Installation of EHY-2000 Device - BioMed Clinic, Bad Bergzabern</span> <span><span lang="" about="http://oncotherm.com/en/user/1" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">admin</span></span> <span>Tue, 04/10/2018 - 07:06</span> <div class="c-rich-text"><p>BioMed clinic is a hospital for acute oncology cases, which combines conventional medicine with methods from complementary cancer therapy.</p> <p></p><p></p>Dr. H. Friedrich Migeod MD. is the chief physician of the BioMed-Hospital, Bad Bergzabern (see picture above). <p>BioMed clinic is a longtime and a successful user of Oncotherm. BioMed has two EHY-2000+ devices and one EHY-2000 device. The newest installation took place in November 2017.</p> </div> <!-- Generator: Adobe Illustrator 19.2.1, SVG Export Plug-In --> <div> <div class="swiper-container j-featured-swiper"> <div class="swiper-wrapper"> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/2018-04/Dr.%20Friedrich%20Migeod_0.jpg?itok=1AWkmSEU" width="400" height="225" alt="Dr. Friedrich Migeod" typeof="foaf:Image" /><figcaption> Dr. Friedrich Migeod </figcaption></figure></div> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/2018-04/Bad%20Bergzabern%20Bild%202.jpg?itok=y6yylwVP" width="400" height="267" alt="Oncotherm EHY-2000 device in the BioMed clinic, Bad Bergzabern" typeof="foaf:Image" /><figcaption> Oncotherm EHY-2000 device in the BioMed clinic, Bad Bergzabern </figcaption></figure></div> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/2018-04/BioMed%20Klinik_0.jpg?itok=-yYBTlY_" width="400" height="208" alt="BioMed Clinic" typeof="foaf:Image" /><figcaption> BioMed Clinic </figcaption></figure></div> </div> <div class="swiper-pagination"></div> <div class="swiper-button-prev"></div> <div class="swiper-button-next"></div> </div> </div> <a href="http://oncotherm.com/en/taxonomy/term/39" hreflang="en">Clinical</a> Tue, 10 Apr 2018 07:06:51 +0000 admin 1292 at http://oncotherm.com New installation in Granada, Spain http://oncotherm.com/en/news-events/new-installation-granada-spain <span>New installation in Granada, Spain</span> <span><span lang="" about="http://oncotherm.com/en/user/1" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">admin</span></span> <span>Mon, 11/27/2017 - 11:25</span> <div class="c-rich-text"><p align="center" style="text-align:center"><b>New installation in Granada</b></p> <p align="center" style="text-align:center"> </p> <p align="center" style="text-align:center">We are pleased to welcome</p> <p align="center" style="text-align:center"><b>CLINICA CHECA</b></p> <p align="center" style="text-align:center">as a new Oncotherm user</p> <p align="center" style="text-align:center"><b>in Granada Spain.</b></p> <p align="center" style="text-align:center"> </p> <p align="center" style="text-align:center">Take a look at the pictures of the modern designed clinic</p> <p align="center" style="text-align:center">where the EHY-2000 device was installed in November.</p> </div> <!-- Generator: Adobe Illustrator 19.2.1, SVG Export Plug-In --> <div> <div class="swiper-container j-featured-swiper"> <div class="swiper-wrapper"> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/2017-11-22-PHOTO-00000544.jpg?itok=lnG1KNvk" width="400" height="300" alt="Clinica Checa-EHY-2000plus" typeof="foaf:Image" /><figcaption> Clinica Checa-EHY-2000plus </figcaption></figure></div> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/Clinica%20Checa.PNG?itok=zjco82pB" width="400" height="209" alt="Entrance of the Clinica Checa " typeof="foaf:Image" /><figcaption> Entrance of the Clinica Checa </figcaption></figure></div> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/Clinica%20Checa_waiting%20room.PNG?itok=FKmBxiyn" width="400" height="260" alt="Clinica Checa-waiting room " typeof="foaf:Image" /><figcaption> Clinica Checa-waiting room </figcaption></figure></div> </div> <div class="swiper-pagination"></div> <div class="swiper-button-prev"></div> <div class="swiper-button-next"></div> </div> </div> <a href="http://oncotherm.com/en/taxonomy/term/39" hreflang="en">Clinical</a> <a href="http://oncotherm.com/en/taxonomy/term/6" hreflang="en">Internal News</a> Mon, 27 Nov 2017 11:25:55 +0000 admin 1187 at http://oncotherm.com 1.5 billion-forint grant for tumour therapy device http://oncotherm.com/en/news-events/15-billion-forint-grant-tumour-therapy-device <span>1.5 billion-forint grant for tumour therapy device </span> <span><span lang="" about="http://oncotherm.com/en/user/1" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">admin</span></span> <span>Fri, 07/21/2017 - 10:47</span> <div class="c-rich-text"><p style="margin:0in 0in 8pt"> </p> <p style="margin:0in 0in 8pt"> </p> <p><strong>Beneficiary Name</strong>: Oncotherm Kft. and Semmelweis University</p> <p><strong>Title of the project</strong>: „Improving the efficiency of the electromagnetic tumour therapy device and the preparation for its integration into commercial use”</p> <p><strong>Amount of contracted support</strong>: 1,472 billion forints</p> <p><strong>Support rate</strong>: 88.94%</p> <p><strong>Projected completion </strong><strong>date</strong> : 31.12.2019</p> <p><strong>Project ID number</strong> : NVKP_16-1-2016-0042</p> <p>The tender “Improving the efficiency of the electromagnetic tumour therapy device and the preparation for its integration into commercial use” lead by Semmelweis University received a grant of 1.472 billion forints as part of the Hungarian Competitiveness and Excellence Programme launched in 2016. The programme promotes and supports projects that contribute to the more efficient treatment of endemic diseases by R&D&I developments.<span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:"Calibri",sans-serif">                     </span></span></span><span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:"Calibri",sans-serif">                                                                                   </span></span></span></p> <p style="margin:0in 0in 8pt">                        </p> <p>The project is realised in a consortium of Semmelweis University and Oncotherm Kft, which has taken part in the development of oncothermia, a new therapeutic method. The method is based on the in situ radio frequency modulation of cells which triggers responses that locally inhibit tumour growth and trigger tumour specific immune reactions by causing immunogenic cell death. As a result of immunogenic cell death the treatment applied on the primary tumour may be converted into a systemic antitumour process, which may prevent metastasis or enable the therapeutic control of the existing metastases.</p> <p>"The method is already in use in clinical practice as an adjuvant therapy. The research aims to increase the efficiency of the method.”, said Dr. Zoltán Benyó, Director of the Institute of Clinical Experimental Research and project leader.The program is based on preclinical and cinical studies and is completed by device development.<span style="font-size:11pt"><span style="line-height:normal"><span style="font-family:"Calibri",sans-serif"><span style="font-size:12.0pt"><span style="font-family:"Times New Roman",serif">                            </span></span><a href="http://semmelweis.hu/hirek/files/2015/09/RS31657_DankMagdolna_fotó-scr.jpg"><span style="font-size:12.0pt"><span style="font-family:"Times New Roman",serif"><span style="color:blue"><span style="text-decoration:none"><span style="text-underline:none"> </span></span></span></span></span></a><rect alt="data:image/gif;base64,R0lGODlhAQABAPABAP///wAAACH5BAEKAAAALAAAAAABAAEAAAICRAEAOw==" filled="f" id="Rectangle_x0020_2" o:gfxdata="UEsDBBQABgAIAAAAIQC75UiUBQEAAB4CAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKSRvU7DMBSF dyTewfKKEqcMCKEmHfgZgaE8wMW+SSwc27JvS/v23KTJgkoXFsu+P+c7Ol5vDoMTe0zZBl/LVVlJ gV4HY31Xy4/tS3EvRSbwBlzwWMsjZrlprq/W22PELHjb51r2RPFBqax7HCCXIaLnThvSAMTP1KkI +gs6VLdVdad08ISeCho1ZLN+whZ2jsTzgcsnJwldluLxNDiyagkxOquB2Knae/OLUsyEkjenmdzb mG/YhlRnCWPnb8C898bRJGtQvEOiVxjYhtLOxs8AySiT4JuDystlVV4WPeM6tK3VaILeDZxIOSsu ti/jidNGNZ3/J08yC1dNv9v8AAAA//8DAFBLAwQUAAYACAAAACEArTA/8cEAAAAyAQAACwAAAF9y ZWxzLy5yZWxzhI/NCsIwEITvgu8Q9m7TehCRpr2I4FX0AdZk2wbbJGTj39ubi6AgeJtl2G9m6vYx jeJGka13CqqiBEFOe2Ndr+B03C3WIDihMzh6RwqexNA281l9oBFTfuLBBhaZ4ljBkFLYSMl6oAm5 8IFcdjofJ0z5jL0MqC/Yk1yW5UrGTwY0X0yxNwri3lQgjs+Qk/+zfddZTVuvrxO59CNCmoj3vCwj MfaUFOjRhrPHaN4Wv0VV5OYgm1p+LW1eAAAA//8DAFBLAwQUAAYACAAAACEAfM8ItyIDAADTBgAA HwAAAGNsaXBib2FyZC9kcmF3aW5ncy9kcmF3aW5nMS54bWykVdty0zAQfWeGf9DoGdd2cC42uIzj JKVDoaWhH6DYiq1BloykXArDv7OSnSZtGR6oZxKvpNXR2bO78vsP+4ajLVWaSZHi8CzAiIpClkxU Kb77tvAmGGlDREm4FDTF91TjD+evX70nSaVIW7MCAYLQCUlxbUyb+L4uatoQfSZbKmBtLVVDDAxV 5ZeK7AC54f4gCEZ+Q5jA50eoGTEEbRT7Dygui++0zInYEg2QvEhOZ3qOvHg5MknE9kK1y/ZGWebF l+2NQqxMMSgnSAMSYb9f6N1g6D/ZVR0B9mvVWH+5XqO9Q7m3/w6D7g0qYDJ8G48DwC9gqbe7M+rr v+wq6vk/9wGZ7lAwTojo1tIQ2+eRDQ6R3dICSqHiFMFUSXWhUlxCzhLWkIr6FVu/WxFNR9Gb24Bf XM94nX3NptmN/fm+v8uyLP84nGbzT2BlV/Yvg7VsDq/L/Bbe17s0fdDvwES3V5BdjYTMazieZroF IiAF8DpMKSV3NSWlttOd4pCaDsGpfwSDfK12n2UJqSIbI10B/n8WHtQkSau0uaCyQdZIsQKSDpxs r7TpOB1cnNRywTh3ieTi0QRgdjNQALDVrtlScJ3xKw7i+WQ+ibxoMJp7UTCbedkij7zRIhwPZ29n eT4Lf9tzwyipWVlSYY85dGkYPWuBhhVKark2Z4VsfKhDVtBDp0KfhsGxT7XkrLRwlpJW1SrnCm0J T/HCPb3yJ27+YxquFSCWJyGFgyiYDmJvMZqMvWgRDT0o+IkXhPE0HgVRHM0Wj0O6YoK+PCS0S3E8 HAxdlk5IP4ktcM/z2EjSMEMV4qxJ8eTBiSS2EOeidKk1hPHOPpHC0j9KAek+JBpM3d8sZr90HWn2 U1neW8FW8IbiVRKKC24DuLXBqKX6idEO7uIU6x8boihG/FJAH8RhFIGbcYNoOB7AQJ2urE5XiCgA KsUGo87MDYxgy6ZVrKrhpNDJJGQGTbNmfUF3nCw7rs3S3HPqonbMqShviCK3wJlD36aYCu9u2esI HhDsMbiNpsvWXjBdo3TROznA8cl17rb2nx/7zTgdn/8BAAD//wMAUEsDBBQABgAIAAAAIQCSfYfg HQcAAEkgAAAaAAAAY2xpcGJvYXJkL3RoZW1lL3RoZW1lMS54bWzsWUtvGzcQvhfof1jsvbFkvWIj cmDJctzEL0RKihwpidplzF0uSMqObkVy6qVAgbTooQF666EoGqABGvTSH2PAQZv+iA65L1Ki4gdc IChsAcbu7DfD4czszOzwzt1nEfWOMReExW2/eqviezgesTGJg7b/aLD92W3fExLFY0RZjNv+DAv/ 7sann9xB6yNKkiFDfDwIcYQ9EBSLddT2QymT9ZUVMQIyErdYgmN4NmE8QhJuebAy5ugEFojoymql 0lyJEIn9DZAolaAehX+xFIoworyvxGAvRhGsfjCZkBHW2PFRVSHETHQp944Rbfsgc8xOBviZ9D2K hIQHbb+i//yVjTsraD1jonIJr8G3rf8yvoxhfLSq1+TBsFi0Xm/Um5uFfA2gchHXa/WavWYhTwPQ aAQ7TXWxZbZWu/UMa4DSS4fsrdZWrWrhDfm1BZ03G+pn4TUolV9fwG9vd8GKFl6DUnxjAd/orHW2 bPkalOKbC/hWZXOr3rLka1BISXy0gK40mrVuvtsCMmF0xwlfa9S3W6uZ8BIF0VBEl1piwmK5LNYi 9JTxbQAoIEWSxJ6cJXiCRhCTXUTJkBNvlwQhBF6CYiaAXFmtbFdq8F/96vpKexStY2RwK71AE7FA Uvp4YsRJItv+fZDqG5Czt29Pn785ff776YsXp89/zdbWoiy+HRQHJt/7n77559WX3t+//fj+5bfp 0vN4YeLf/fLVuz/+/JB42HFpirPvXr978/rs+6//+vmlQ/omR0MTPiARFt4+PvEesgg26NAfD/nl OAYhIibHZhwIFCO1ikN+T4YWen+GKHLgOti242MOqcYFvDd9aincD/lUEofEB2FkAfcYox3GnVZ4 oNYyzDyYxoF7cT41cQ8ROnat3UWx5eXeNIEcS1wiuyG21DykKJYowDGWnnrGjjB27O4JIZZd98iI M8Em0ntCvA4iTpMMyNCKppJph0Tgl5lLQfC3ZZu9x16HUdeut/CxjYR3A1GH8gNMLTPeQ1OJIpfI AYqoafBdJEOXkv0ZH5m4npDg6QBT5vXGWAgXzwGH/RpOfwBpxu32PTqLbCSX5MglcxcxZiK32FE3 RFHiwvZJHJrYz8URhCjyDpl0wfeY/Yaoe/ADipe6+zHBlrvPzwaPIMOaKpUBop5MucOX9zCz4rc/ oxOEXalmk0dWit3kxBkdnWlghfYuxhSdoDHG3qPPHRp0WGLZvFT6fghZZQe7Aus+smNV3cdYYE83 N4t5cpcIK2T7OGBL9NmbzSWeGYojxJdJ3gevmzbvQamLXAFwQEdHJnCfQL8H8eI0yoEAGUZwL5V6 GCKrgKl74Y7XGbf8d5F3DN7Lp5YaF3gvgQdfmgcSu8nzQdsMELUWKANmgKDLcKVbYLHcX7Ko4qrZ pk6+if3Slm6A7shqeiISn9sBzfU+jf+u94EO4+yHV46X7Xr6HbdgK1ldstNZlkx25vqbZbj5rqbL +Jh8/E3NFprGhxjqyGLGuulpbnoa/3/f0yx7n286mWX9xk0n40OHcdPJZMOV6+lkyuYF+ho18EgH PXrsEy2d+kwIpX05o3hX6MGPgO+Z8TYQFZ+ebuJiCpiEcKnKHCxg4QKONI/HmfyCyLAfogSmQ1Vf CQlEJjoQXsIEDI002Slb4ek02mPjdNhZrarBZlpZBZIlvdIo6DCokim62SoHeIV4rW2gB625Aor3 MkoYi9lK1BxKtHKiMpIe64LRHEronV2LFmsOLW4r8bmrFrQA1QqvwAe3B5/pbb9RBxZggnkcNOdj 5afU1bl3tTOv09PLjGlFADTYeQSUnl5Tui7dntpdGmoX8LSlhBFuthLaMrrBEyF8BmfRqagXUeOy vl4rXWqpp0yh14PQKtVo3f6QFlf1NfDN5wYam5mCxt5J22/WGhAyI5S0/QkMjeEySiB2hPrmQjSA 45aR5OkLf5XMknAht5AIU4PrpJNmg4hIzD1Koravtl+4gcY6h2jdqquQED5a5dYgrXxsyoHTbSfj yQSPpOl2g6Isnd5Chk9zhfOpZr86WHGyKbi7H45PvCGd8ocIQqzRqioDjomAs4Nqas0xgcOwIpGV 8TdXmLK0a55G6RhK6YgmIcoqipnMU7hO5YU6+q6wgXGX7RkMapgkK4TDQBVY06hWNS2qRqrD0qp7 PpOynJE0y5ppZRVVNd1ZzFohLwNztrxakTe0yk0MOc2s8Gnqnk+5a3mum+sTiioBBi/s56i6FygI hmrlYpZqSuPFNKxydka1a0e+wXNUu0iRMLJ+Mxc7Z7eiRjiXA+KVKj/wzUctkCZ5X6kt7TrY3kOJ NwyqbR8Ol2E4+Ayu4HjaB9qqoq0qGlzBmTOUi/SguO1nFzkFnqeUAlPLKbUcU88p9ZzSyCmNnNLM KU3f0yeqcIqvDlN9Lz8whRqWHbBmvYV9+r/xLwAAAP//AwBQSwMEFAAGAAgAAAAhAJxmRkG7AAAA JAEAACoAAABjbGlwYm9hcmQvZHJhd2luZ3MvX3JlbHMvZHJhd2luZzEueG1sLnJlbHOEj80KwjAQ hO+C7xD2btJ6EJEmvYjQq9QHCMk2LTY/JFHs2xvoRUHwsjCz7DezTfuyM3liTJN3HGpaAUGnvJ6c 4XDrL7sjkJSl03L2DjksmKAV201zxVnmcpTGKSRSKC5xGHMOJ8aSGtHKRH1AVzaDj1bmIqNhQaq7 NMj2VXVg8ZMB4otJOs0hdroG0i+hJP9n+2GYFJ69elh0+UcEy6UXFqCMBjMHSldnnTUtXYGJhn39 Jt4AAAD//wMAUEsBAi0AFAAGAAgAAAAhALvlSJQFAQAAHgIAABMAAAAAAAAAAAAAAAAAAAAAAFtD b250ZW50X1R5cGVzXS54bWxQSwECLQAUAAYACAAAACEArTA/8cEAAAAyAQAACwAAAAAAAAAAAAAA AAA2AQAAX3JlbHMvLnJlbHNQSwECLQAUAAYACAAAACEAfM8ItyIDAADTBgAAHwAAAAAAAAAAAAAA AAAgAgAAY2xpcGJvYXJkL2RyYXdpbmdzL2RyYXdpbmcxLnhtbFBLAQItABQABgAIAAAAIQCSfYfg HQcAAEkgAAAaAAAAAAAAAAAAAAAAAH8FAABjbGlwYm9hcmQvdGhlbWUvdGhlbWUxLnhtbFBLAQIt ABQABgAIAAAAIQCcZkZBuwAAACQBAAAqAAAAAAAAAAAAAAAAANQMAABjbGlwYm9hcmQvZHJhd2lu Z3MvX3JlbHMvZHJhd2luZzEueG1sLnJlbHNQSwUGAAAAAAUABQBnAQAA1w0AAAAA " stroked="f" style="width:11pt; height:11pt; v-text-anchor:top"><lock aspectratio="t" v:ext="edit"><wrap type="none"><anchorlock></anchorlock></wrap></lock></rect><span style="font-size:12.0pt"><span style="font-family:"Times New Roman",serif"> </span></span></span></span></span></p> <p>The preclinical module is coorinated by the Institute of Clinical Experimental Research where the local and systemic effects of the oncothermia therapy are studied on animal models and the processes behind these effects are analysed on the levels of cells, organs and the organism. The main objectives are the identification and the understanding of processes of tumour immunology and angiogenesis on a molecular level. These processes could be manipulated by oncothermia therapy, which could enable the clinical application of the method in the therapy of cancerous diseases of great prevalence and poor prognosis (eg. mammary carcinoma, melanoma, glioblastoma).</p> <p>Research of the clinical module takes place in the Centre of Oncology, lead by Dr. Magdolna Dank, Director. A substantial number of patients with pancreatic cancer have already been involved in the studies and received treatment by the oncothermia device with promising preliminary results. The objective is to develop therapeutic recommendations which will serve as a basis for determining the target group and therapeutic protocol of oncothermia therapy.</p> <p>Based on the results gained from preclinical testing and experiences from the clinical module the industrial partner will further develop the device, thus creating a machine that satisfies real market needs. One of the greatest achievements of the cooperation is Oncotherm Kft.’s commitment to create an international exhibition and training center at Semmelweis University.                            </p> <p>The programme supported by the National Research, Development and Innovation Office involves nearly 30 researchers and their assistants. The cooperation of the consortium partners is an excellent example of the realisation of research and a practical, marketable product.</p> <p>Source: Institute of Clinical Experimental Research<br /> Photo: Attila Kovács – Semmelweis University<br /> Translation: Ágnes Raubinek</p> </div> <!-- Generator: Adobe Illustrator 19.2.1, SVG Export Plug-In --> <div> <div class="swiper-container j-featured-swiper"> <div class="swiper-wrapper"> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/EHZ-2030_ugyvezetokkel_0.jpg?itok=MuX5xKqv" width="400" height="205" alt="Balázs Ács and Dr.Olivér Szász - general managers of Oncotherm Kft." typeof="foaf:Image" /><figcaption> Balázs Ács and Dr.Olivér Szász - general managers of Oncotherm Kft. </figcaption></figure></div> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/Dr.%20Beny%C3%B3%20Zolt%C3%A1n_0.jpg?itok=35XfoukS" width="200" height="177" alt="Dr. Zoltán Benyó - Director of the Institute of Clinical Experimental Research and project leader" typeof="foaf:Image" /><figcaption> Dr. Zoltán Benyó - Director of the Institute of Clinical Experimental Research and project leader </figcaption></figure></div> </div> <div class="swiper-pagination"></div> <div class="swiper-button-prev"></div> <div class="swiper-button-next"></div> </div> </div> <div class="field field--name-field-url field--type-link field--label-hidden field__item"><a href="http://semmelweis.hu/english/news/2017/07/1-5-billion-forint-grant-for-tumour-therapy-device/" target="_blank">1.5 billion-forint grant for tumour therapy device </a></div> <a href="http://oncotherm.com/en/taxonomy/term/39" hreflang="en">Clinical</a> <a href="http://oncotherm.com/en/taxonomy/term/5" hreflang="en">External News</a> Fri, 21 Jul 2017 10:47:01 +0000 admin 982 at http://oncotherm.com Transurethral prostate hyperthermia http://oncotherm.com/en/news-events/transurethral-prostate-hyperthermia <span>Transurethral prostate hyperthermia</span> <span><span lang="" about="http://oncotherm.com/en/user/1" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">admin</span></span> <span>Mon, 07/10/2017 - 08:00</span> <div class="c-rich-text"><h3>Prostata hyperthermia</h3> <p>The prostate hyperthermia can be considered as an alternative to radical prostatectomy for prostate cancer and benign prostatic enlargement, but also in prostatitis pain symptom.</p> <p>In prostate cancer usually concomitant hormone therapy is recommended. With prostate hyperthermia can also be treated without prior biopsy, see: <a href="http://www.dr-kleef.at/en/prostata#biopsie_or_operation">Biopsy? Surgery?</a></p> <p>The prostate hyperthermia is an alternative to surgical treatment measures, should the existing symptoms not improve, and/or should the cancer not respond enough, a necessary surgery or radiotherapy after thermotherapy treatment is possible at any time.</p> <h3>Procedure:</h3> <p>After injecting a local anesthesia and lubricant into the urethra, a special catheter is inserted and fixed. During therapy, the patient lies on a comfortable couch. He is connected to the catheter with the therapy device. The unit heats the prostate to 48 to 52 degrees and holds this temperature during the typically required 180 minutes.</p> <p>This leads to a selective destruction of cancerous tissue in the prostate. Characterized in that the tumor tissue dies in the surrounding healthy tissue and organs are not damaged, immune cells are activated, which transport away the dead tissue, and present it to other immune cells, such that there may be a specific immune development.</p> <p>General anesthesia is not required, but only a local anesthetic. The therapy can be performed as an outpatient. Usually only two treatments are necessary.</p> <h2>Transurethral prostate hyperthermia</h2> <p>Hyperthermia treatments for prostate problems or illnesses have been established as one of the most successful therapies at our center. The key treatment is a transurethral hyperthermia and as an important addition a short series of mild - moderate whole body hyperthermia treatments. Your individual treatment will be carefully planned based on the symptoms and present findings.</p> <h3>Prostatitis (prostate inflammation):</h3> <p>A cure for this disease - often young men - can be can be difficult. In to 90 percent (!) of inflammation of the prostate is – according to a publication of the German Medical Journal – the inflammation is not caused by bacteria, so antibiotics are not indicated <a href="http://www.ncbi.nlm.nih.gov/pubmed/19568373" target="_blank">[1]</a>. Our multimodal therapy approach with hyperthermia and natural healing substances has proven to be very effective in chronic prostatitis.</p> <p> </p> <p>Symptoms of prostatitis may include pain in the lower abdomen and back, problems with urination, feeling of pressure in the perineal area, pain during intercourse and also an elevated PSA level. Therapeutically antibiotics are indicated in the (rare) bacterial prostate inflammation, in non-bacterial prostatitis whole body hyperthermia, local deep hyperthermia of the prostate, a prostate thermal therapy and an individual orthomolecular approach based on laboratory analysis with anti-inflammatory and immune modulating substances can be very helpful.</p> <p><a href="http://www.ncbi.nlm.nih.gov/pubmed/19568373" target="_blank">[1] Dtsch Arztebl Int. 2009 Mar;106(11):175-83. Epub 2009 Mar 13.</a></p> <h2>Prostatic hyperplasia (prostate enlargement)</h2> <p>In benign prostate enlargement, which in extreme cases may result in surgery or wearing of a catheter, we were able to achieve impressive results with hyperthermia treatment.</p> <p>Benign prostatic hyperplasia is a common disease in men aged 50 years with an approximate incidence of every 10th man. It is caused by nodes (adenomas) that grow in different sizes and often push onto the urethra or the bladder. This results in frequent urination and the weakening of the urinary flow.</p> <h2>Prostate Cancer</h2> <p>As long as the cancer is confined to the prostate, a complete cure is possible. Five years after the initial therapy 80% of patients are alive today when the tumor is detected early; if it is confined to the prostate, more than 90%. In order to remove the tumor almost reflexively surgery (prostatectomy) or radiation therapy has been suggested and implemented. This results in the risk of side effects such as incontinence and erectile dysfunction.</p> <p>More and more often today gentle methods, as well as a wait and see attitude (watch & wait) - especially in the elderly - have its place and will be chosen instead of the invasive method such as prostatectomy. Many men do so - after careful education and treatment planning - the method of local prostate hyperthermia in combination with some temporary hormonal therapy and comprehensive rehabilitation program in orthomolecular medicine - with good success. But also in combination with radiation therapy, hyperthermia offers a valuable synergy - Hyperthermia enhances the oxygen partial pressure in cancer tissues, thus increasing the sensitivity to ionizing radiation.</p> </div> <!-- Generator: Adobe Illustrator 19.2.1, SVG Export Plug-In --> <div> <div class="swiper-container j-featured-swiper"> <div class="swiper-wrapper"> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/Dr.Kleef_EHY-1020IL.PNG?itok=1R59S0Uf" width="400" height="218" alt="Dr.Kleef - Prostata cancer treatment with EHY-1020 IL" typeof="foaf:Image" /><figcaption> Dr.Kleef - Prostata cancer treatment with EHY-1020 IL </figcaption></figure></div> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/Prostata%20hyperthermia.PNG?itok=VB7iP72A" width="311" height="334" alt="Prostata oncothermia " typeof="foaf:Image" /><figcaption> Prostata oncothermia </figcaption></figure></div> </div> <div class="swiper-pagination"></div> <div class="swiper-button-prev"></div> <div class="swiper-button-next"></div> </div> </div> <div class="field field--name-field-url field--type-link field--label-hidden field__item"><a href="http://www.dr-kleef.at/en/prostate_hyperthermia" target="_blank">Transurethral prostate hyperthermia</a></div> <a href="http://oncotherm.com/en/taxonomy/term/5" hreflang="en">External News</a> <a href="http://oncotherm.com/en/taxonomy/term/39" hreflang="en">Clinical</a> <a href="http://oncotherm.com/en/taxonomy/term/37" hreflang="en">Product - EHY-1020 IL</a> Mon, 10 Jul 2017 08:00:04 +0000 admin 647 at http://oncotherm.com What is Transurethral Hyperthermia? http://oncotherm.com/en/news-events/what-transurethral-hyperthermia <span>What is Transurethral Hyperthermia?</span> <span><span lang="" about="http://oncotherm.com/en/user/1" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">admin</span></span> <span>Mon, 07/10/2017 - 07:09</span> <div class="c-rich-text"><p>Most of the available research on transurethral hyperthermia to treat prostate cancer has been written and published by the German cancer clinics that offer the treatment.</p> <p>In layman’s terms, transurethral hyperthermia involves using radio waves to heat the prostate via a specially equipped catheter. Radio frequencies are then pulsed into the prostate, heating the cancer cells to between 113 and 158 degrees. Proponents of this treatment claim that cancer cells have a different blood supply than normal cells, so they either die or become so damaged from the heat they can no longer reproduce while the surrounding (normal) cells are not affected.</p> <p>When we arrived at the Marinus am Stein clinic yesterday, Dr. Weber walked us through the procedure in detail, showing us both a traditional catheter and the specialized catheter. (I was pleased and relieved to see that the specialized catheter was a legitimate medical instrument in a sealed sterile package — and not some “Rube Goldberg” contraption put together by a mad German scientist.)</p> <p>Once the catheter is inserted using a local anesthetic, it remains in place for approximately two hours. Paul will have two of the internal transurethral treatments while we are here (on Tuesday and on Thursday.) On the other days he will have external hyperthermia treatments which are non-invasive.</p> </div> <!-- Generator: Adobe Illustrator 19.2.1, SVG Export Plug-In --> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/Clinik%20Marinus%20am%20Stein.jpg?itok=BiT8XumF" width="400" height="143" alt="Clinic Marinus am Stein" typeof="foaf:Image" /><figcaption> Clinic Marinus am Stein </figcaption></figure><div class="field field--name-field-url field--type-link field--label-hidden field__item"><a href="https://healinganddealing.com/2015/09/08/wtf-is-transurethral-hyperthermia/" target="_blank">Transurethral hyperthermia</a></div> <a href="http://oncotherm.com/en/taxonomy/term/39" hreflang="en">Clinical</a> <a href="http://oncotherm.com/en/taxonomy/term/37" hreflang="en">Product - EHY-1020 IL</a> <a href="http://oncotherm.com/en/taxonomy/term/5" hreflang="en">External News</a> Mon, 10 Jul 2017 07:09:54 +0000 admin 646 at http://oncotherm.com Benign prostatic diseases, prostate cancer can be effectively treated by EHY-1020 IL at St. George Hospital http://oncotherm.com/en/news-events/benign-prostatic-diseases-prostate-cancer-can-be-effectively-treated-ehy-1020-il-st <span>Benign prostatic diseases, prostate cancer can be effectively treated by EHY-1020 IL at St. George Hospital</span> <span><span lang="" about="http://oncotherm.com/en/user/1" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">admin</span></span> <span>Fri, 07/07/2017 - 06:18</span> <div class="c-rich-text"><h3>Prostate Hyperthermia Center</h3> <p>Men’s health encompasses vitality, physical and mental fitness, optimization of cardiovascular function, blood pressure, metabolism, diet, hormonal and immune status. By creating risk profiles, we can perform preventive diagnostics and provide suggestions so that men know their risks and can influence their health through lifestyle changes, physical activity and relaxation techniques that can have a positive impact on their wellbeing and life expectancy. This allows men to take their health into their own hands in order to sustainably reduce their risk of certain diseases and increase their life expectancy and quality of life.</p> <p>With molecular genetic analysis, it is now possible to identify specific health risks and predispositions and take steps to prevent diseases from occurring:</p> <ul><li>Risk of prostate cancer</li> <li>Risk of cardiovascular disease</li> <li>Risk of Alzheimer’s disease</li> <li>Evaluation of risks associated with hormone replacement therapy</li> <li>Risk of osteoporosis</li> <li>Risk of thrombosis</li> <li>Risk of dyslipidemia</li> <li>Enzyme activity and detoxification functions</li> </ul><p><strong>For many men, prostate problems are a taboo subject. They would rather suffer in secret than go to the doctor. However, early treatment of prostate conditions is extremely important in order to prevent painful and risky surgery or even cancer. Too few men take advantage of prostate cancer screening.</strong><br /><strong>Benign prostate enlargement affects more than 80 percent of men aged over 60.</strong> Prostate conditions and associated problems with emptying the bladder continue to increase from this age onwards. The prostate is normally the size of a chestnut and weighs around 20 grams, but <strong>can begin to enlarge from as early as 40 years old.</strong> The <strong>consequences are a distressing urge to urinate, difficulty urinating, a thin stream of urine and disturbed sleep due to frequent urination</strong>. Significant urinary retention and backing up of urine to the kidneys is particularly dangerous and can lead to uremia (toxic levels of urea in the blood). In addition, the risk of cancer increases with age.</p> <p><strong>The St. George Hospital in Bad Aibling is one of the leading and well-established </strong><strong>centers</strong><strong> for hyperthermia treatment of prostate conditions</strong>. <strong>Benign prostatic diseases such as inflammation of the prostate (prostatitis) and benign prostatic hyperplasia (BPH), as well as prostate cancer, can be treated by local hyperthermia that is guided through the urethra, known as transurethral radiofrequency hyperthermia (TURF).</strong></p> <p>The medical team at the Biomedical Center for Men’s Health will be happy to answer any questions you may have about men’s health.</p> <p><strong>Dr. Deyana Uzunova</strong></p> <p><strong>Specialist in Urology</strong></p> </div> <!-- Generator: Adobe Illustrator 19.2.1, SVG Export Plug-In --> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/st_george_hospital.PNG?itok=ilQPlKlS" width="400" height="238" alt="St. George Hospital - EHY-1020 IL" typeof="foaf:Image" /><figcaption> St. George Hospital - EHY-1020 IL </figcaption></figure><div class="field field--name-field-url field--type-link field--label-hidden field__item"><a href="http://www.st-george-hospital.com/biomedical-center/" target="_blank">Prostate Center at St. George Hospital - Oncotherm device EHY-1020 IL </a></div> <a href="http://oncotherm.com/en/taxonomy/term/39" hreflang="en">Clinical</a> <a href="http://oncotherm.com/en/taxonomy/term/37" hreflang="en">Product - EHY-1020 IL</a> <a href="http://oncotherm.com/en/taxonomy/term/5" hreflang="en">External News</a> Fri, 07 Jul 2017 06:18:23 +0000 admin 630 at http://oncotherm.com Prof. A. Szasz visited the Cellumed Clinic in Spain, Marbella http://oncotherm.com/en/news-events/prof-szasz-visited-cellumed-clinic-spain-marbella <span>Prof. A. Szasz visited the Cellumed Clinic in Spain, Marbella</span> <span><span lang="" about="http://oncotherm.com/en/user/1" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">admin</span></span> <span>Thu, 07/06/2017 - 06:27</span> <div class="c-rich-text"><p>Prof. András Szász visited one of the very active oncothermia clinics in Spain, Marbella. By answering their questions, he explained details of the actual developments and protocols to the doctors and nurses responsible for the treatment. The video shows explanation of oncothermia and its methodology. The reason of its casting was to keep training that values for the actual and potential users in the Spanish-speaking territories of the Globe. Professor Szász provided and especially extended a valuable discussion with Professor Dr. José Luis García Puche and they agreed on a possible common research with the Radiotherapy Department of Granada about oncothermia developments. The video summarizes some of the general points of the discussions, too.</p> <p>Enjoy the<strong><em> video </em></strong>and use it for actual reference in some challenging cases and training of oncothermia.</p> <p><a href="https://www.youtube.com/watch?v=VigvQWPgnVA">Please click here for the part 1 of the video.</a></p> <p><a href="https://www.youtube.com/watch?v=mACspHvQ7tA&t=5s">Please click here for the part 2 of the video.</a></p> </div> <!-- Generator: Adobe Illustrator 19.2.1, SVG Export Plug-In --> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/Cellumed%20Clinic%2C%20Puerto%20Ban%C3%BAs%2C%20Marbella.jpg?itok=woFg-Ps3" width="400" height="225" alt="Cellumed Clinic" typeof="foaf:Image" /><figcaption> Cellumed Clinic </figcaption></figure><a href="http://oncotherm.com/en/taxonomy/term/39" hreflang="en">Clinical</a> <a href="http://oncotherm.com/en/taxonomy/term/6" hreflang="en">Internal News</a> Thu, 06 Jul 2017 06:27:49 +0000 admin 629 at http://oncotherm.com Visit of Prof. Dr. András Szász at Cellumed Clinic in Spain http://oncotherm.com/en/news-events/visit-prof-dr-andras-szasz-cellumed-clinic-spain <span>Visit of Prof. Dr. András Szász at Cellumed Clinic in Spain</span> <span><span lang="" about="http://oncotherm.com/en/user/1" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">admin</span></span> <span>Wed, 06/14/2017 - 10:44</span> <div class="c-rich-text"><p>Discussions with Dr. José Luis García Puche was intensively oriented for the further development of the Oncothermia at the Cellumed Clinic as well as decided a cooperation between Prof. Dr. András Szász and Radiotherapy Department of Granada.</p> </div> <!-- Generator: Adobe Illustrator 19.2.1, SVG Export Plug-In --> <div> <div class="swiper-container j-featured-swiper"> <div class="swiper-wrapper"> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/cellumed-kGpC-U30480576881WMI-575x323%40Diario%20Sur.jpg?itok=IK8s0nvj" width="400" height="225" alt="Prof. András Szász at Cellumed Clinic" typeof="foaf:Image" /><figcaption> Prof. András Szász at Cellumed Clinic </figcaption></figure></div> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/cellumed2-kGpC-U30480576881GYF-575x323%40Diario%20Sur.jpg?itok=ZmHxQ3Oh" width="400" height="225" alt="Ms. Rosa Sánchez, director of the CMH and Prof. Dr. András Szász" typeof="foaf:Image" /><figcaption> Ms. Rosa Sánchez, director of the CMH and Prof. Dr. András Szász </figcaption></figure></div> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/Cellumed%20Clinic%2C%20Puerto%20Ban%C3%BAs%2C%20Marbella.jpg?itok=woFg-Ps3" width="400" height="225" alt="Cellumed Clinic, Puerto Banús, Marbella" typeof="foaf:Image" /><figcaption> Cellumed Clinic, Puerto Banús, Marbella </figcaption></figure></div> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/Cellumed.JPG?itok=8R9fRG3Q" width="400" height="467" alt="At Cellumed" typeof="foaf:Image" /><figcaption> At Cellumed </figcaption></figure></div> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/cellumed_.jpg?itok=r0QklZl8" width="317" height="179" alt="" typeof="foaf:Image" /><figcaption></figcaption></figure></div> </div> <div class="swiper-pagination"></div> <div class="swiper-button-prev"></div> <div class="swiper-button-next"></div> </div> </div> <div class="field field--name-field-url field--type-link field--label-hidden field__item"><a href="http://www.diariosur.es/sociedad/salud/201705/20/prof-andras-szasz-nanothermia-20170519111449.html" target="_blank">Read more about the visit</a></div> <a href="http://oncotherm.com/en/taxonomy/term/5" hreflang="en">External News</a> <a href="http://oncotherm.com/en/taxonomy/term/39" hreflang="en">Clinical</a> Wed, 14 Jun 2017 10:44:28 +0000 admin 179 at http://oncotherm.com New Oncothermia user clinic in North America http://oncotherm.com/en/news-events/new-oncothermia-user-clinic-north-america <span>New Oncothermia user clinic in North America </span> <span><span lang="" about="http://oncotherm.com/en/user/1" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">admin</span></span> <span>Tue, 03/25/2014 - 11:51</span> <div class="c-rich-text"><p>Port Moody Health is one of just a few cancer centers in North America to offer Hyperthermia (Modulated Electro-hyperthermia using the Oncotherm EHY-2000), an advanced technology from Germany and a major breakthrough in integrative cancer therapy. Now, Canadians no longer have to travel overseas to receive the most advanced, integrated and potentially life-saving cancer care.</p> <p>Hyperthermia has proven its exceptional value in cancer treatment. In Germany, hyperthermia, (modulated Electro-hyperthermia using the Oncotherm-2000 Plus device)  has for many decades been part of the standard of care for cancer treatment, used concurrently with chemotherapy and radiation. At present, there are over 100,000 hyperthermia treatments (using the oncotherm-200 plus device) provided worldwide every year, to patients with a variety of different cancer types and stages of the disease.</p> <p>Cancer care physician, Dr. Sharon Gurm BSc (Genetics), ND (Naturopathic Physician), FABNO (Board Certified in Naturopathic Oncology) uses hyperthermia in conjunction with other evidence-based therapies that, when strategically integrated, provide the best outcomes for our patients.</p> </div> <!-- Generator: Adobe Illustrator 19.2.1, SVG Export Plug-In --> <div> <div class="swiper-container j-featured-swiper"> <div class="swiper-wrapper"> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/EHY-2000%2002.jpg?itok=LKJEuITV" width="400" height="266" alt="EHY-2000" typeof="foaf:Image" /><figcaption> EHY-2000 </figcaption></figure></div> <div class="swiper-slide"> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/dr-sharon-gurm-closeup-284x284_0.jpg?itok=w4Iiv-SN" width="280" height="209" alt="Dr. Sharon Gurm - Naturopathic Physician of Integrative Oncology and Founder and Medical Director of Port Moody Health Integrative Medicine and Cancer Care" typeof="foaf:Image" /><figcaption> Dr. Sharon Gurm - Naturopathic Physician of Integrative Oncology and Founder and Medical Director of Port Moody Health Integrative Medicine and Cancer Care </figcaption></figure></div> </div> <div class="swiper-pagination"></div> <div class="swiper-button-prev"></div> <div class="swiper-button-next"></div> </div> </div> <div class="field field--name-field-url field--type-link field--label-hidden field__item"><a href="http://www.portmoodyhealth.com/cancer-centre/integrative-cancer-therapies/hyperthermia-oncotherm/" target="_blank">Port Moody Health is one of just a few cancer centers in North America to offer…</a></div> <a href="http://oncotherm.com/en/taxonomy/term/39" hreflang="en">Clinical</a> Tue, 25 Mar 2014 11:51:41 +0000 admin 1229 at http://oncotherm.com Hyperthermia: turning the heat up on cancer http://oncotherm.com/en/news-events/hyperthermia-turning-heat-cancer <span>Hyperthermia: turning the heat up on cancer</span> <span><span lang="" about="http://oncotherm.com/en/user/1" typeof="schema:Person" property="schema:name" datatype="" xml:lang="">admin</span></span> <span>Wed, 01/23/2013 - 14:01</span> <div class="c-rich-text"><p>The Pretoria hospital is the first medical facility in sub-Saharan Africa to offer a new form of hyperthermia for cancer treatment, which has been found to increase patients’ survival chances dramatically in certain types of cancer. </p> <p>For detailed information please visit this page: <a href="http://www.health24.com/Medical/Cancer/Cancer-treatment/Hyperthermia-turning-the-heat-up-on-cancer-20130210">http://www.health24.com/Medical/Cancer/Cancer-treatment/Hyperthermia-turning-the-heat-up-on-cancer-20130210 </a></p> </div> <!-- Generator: Adobe Illustrator 19.2.1, SVG Export Plug-In --> <figure class="c-figure"><img src="http://oncotherm.com/sites/oncotherm/files/styles/crop_thumbnail/public/hospital_bedford-wilgers.jpg?itok=nRI0mH5K" width="400" height="267" alt="Life Wilgers Hospital in Pretoria" typeof="foaf:Image" /><figcaption> Life Wilgers Hospital in Pretoria </figcaption></figure><a href="http://oncotherm.com/en/taxonomy/term/39" hreflang="en">Clinical</a> <a href="http://oncotherm.com/en/taxonomy/term/5" hreflang="en">External News</a> Wed, 23 Jan 2013 14:01:11 +0000 admin 1227 at http://oncotherm.com